On the recordJune 27, 1996
This is indeed a classic case of the public interest versus the special interest. That is exactly what the issue is today on the floor. The Pryor-Brown-Chafee amendment closes a loophole that every expert in this field, from our Patent Office and the Food and Drug Administration to our U.S. Trade Representative, says should be closed. We are also seeking to have the prescription drug industry play by the very same rules as every other industry in our country. The third thing our amendment does, Mr. President, is guarantee that American consumers have access to affordable generic drugs as was intended by the GATT treaty.
Said by
William Pryor
Source
govinfo.gov